Cellistypt®

Product Quick Finder

Choose a category or subcategory

B. Braun Sharing Expertise
Cellistypt®

Oxidized resorbable cellulose hemostats

Product Picture Enlargement CW
Cellistypt®

Cellistypt® is an oxidized resorbable cellulose hemostat, of 100 % vegetable origin made from natural cotton. Oxidized cellulose hemostats have been used for decades and are well known for their hemostatic properties and easy handling. B. Braun’s Cellistypt® product range is available in four different presentations, offering different option to be used to help stopping different kinds of bleeding in the OR.

Features

  • Manufactured from extra-long staple cotton of the finest quality.
  • Achieves hemostasis in approximately 1,5 minutes. [3]
  • Biodegradable, bioresobable and biocompatible. [4]
  • Maintains its original structure. [5]
  • Can be cut to size without fraying. [2]
  • Can be relocated. [5]
  • Absorbed within 14 days (absorption time may vary depending on the quantity of product used, the level of blood saturation and the type of tissue). [3,6]
  • Antimicrobial effect on a large spectrum of pathogens. [7]
  • Easy to use. [2]

Indication

Cellistypt® is indicated for capillary, venous and minor arterial bleedings when conventional hemostatic measures such as sutures or ligatures are ineffective or unfeasible. [2]

  • Cellistypt®: Regular density knitted fabric
  • Cellistypt® D-K: High density knitted fabric
  • Cellistypt® F: Regular density fibrous version
  • Cellistypt® N-W: Reduced weight reinforced fibrous version

[2] Based on Cellistypt® Instructions For Use

[3] Jindřich Lahovský, MD. Evaluation of efficacy and safety of medical devices series OKCEL®. Study Report Ref. No AP-SY-1501. Data on file: 18640–033.

[4] Based on biocompatibility testing of OKCEL® products in accordance with EN ISO 10993. Data on file:18640-033.

[5] Jindřich Lahovský, MD. Závěrečná zpráva laboratorního vyhodnocení vlastností hemostatik na bázi oxidované regenerované a neregenerované celulózy. Study Report Ref. No. AP-SY-1901. Data on file: 18640 – 034.

[6] Jindřich Lahovský, MD. Evaluation of efficacy and safety of the medical device OKCEL® S. Study Report Ref. No AP-SY-1701. Data on file: 18640–033.

[7] Ing. Iveta Brožková, Ph. D. Department of Biological and Biochemical Sciences at the Faculty of Chemical Technology, University of Pardubice. Final report on testing the antimicrobial activity of the product OKCEL®. Data on file: 18640–034.

[8] Lewis KM, Spazierer D, Urban MD, Lin L, Redl H, Goppelt A. Comparison